The locus coeruleus calcitonin receptor can Be engaged by amylin and calcitonin gene-related peptide to suppress feeding without inducing nausea. [PDF]
Mol MetabFortin SM +8 more
europepmc +1 more source
The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies. [PDF]
Biosci RepPatil M +4 more
europepmc +1 more source
Brain Amylin Signaling, Feeding, and Reward. [PDF]
Compr PhysiolMietlicki-Baase EG.
europepmc +1 more source
Positioning Incretin-Based and Next-Generation Obesity Management Medications: A Methodological Framework for a Series of Systematic Reviews and Network Meta-Analyses. [PDF]
Diabetes Obes MetabMonami M, Ragghianti B, Mannucci E.
europepmc +1 more source
Recent developments in GPCR signalling in appetite regulation. [PDF]
Biosci RepBrittain HR, Gorvin CM.
europepmc +1 more source
Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies. [PDF]
J Clin MedBijoch J.
europepmc +1 more source
Advances in the management of obesity: non-pharmacological strategies, herbal formulations, current pharmacotherapy, emerging drugs, and future perspectives. [PDF]
Front Endocrinol (Lausanne)Mehetre KN, Dawane JS.
europepmc +1 more source
A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy. [PDF]
Pharmaceuticals (Basel)Lee S, Song H, Kwon Y.
europepmc +1 more source
Anti-Obesity Medications in Longevity and Aesthetic Medicine. [PDF]
J Clin MedBijoch J.
europepmc +1 more source
Peptide Hormones in Appetite Regulation: A Complex Network. [PDF]
Pharmaceuticals (Basel)Abdollahi S, Adam H, Al Musaimi O.
europepmc +1 more source